Kathryn Jean Boor - 02 Jun 2022 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Director
Signature: /s/ Ryan Brown, as Attorney-in-Fact for Kathryn Boor
Issuer symbol: SRPT
Transactions as of: 02 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2022, 20:24:36 UTC
Previous filing: 06 May 2022
Next filing: 08 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Award	$0	+4,908		$0.000000	4,908	02 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Option (right to buy)	Award	$0	+8,329		$0.000000	8,329	02 Jun 2022	Common Stock	8,329	$72.58	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning June 2, 2023.
F2	The option vests in three equal annual installments beginning June 2, 2023.